Beam Therapeutics Stock News & Updates

[WKN: A2PY7P | Symbol: BEAM]
Beam Therapeutics

Escalation in the Middle Eastern Conflict Pushes DAX Well Below the 25,000 Point Mark - Chip Stocks Under Pressure Following Weak Indicators from Asia - Carl Zeiss Meditec Firm After Upgrade - Basler In Demand After Warburg Study - Lufthansa Suffers from Rising Oil Prices and Citigroup Downgrade - Beam Therapeutics in Focus After HC Wainwright Study!

Beam Therapeutics: Base Editing Offers Billion-Dollar Potential in Genetic Precision Medicine

Beam Therapeutics will submit the FDA approval application for BEAM-101 for the treatment of severe...

Beam Therapeutics: Canaccord Sees Around 162% Upside Potential - BEAM-302 Data at End of Q1 Could Boost Stock Price

Beam Therapeutics (BEAM) has announced significant regulatory breakthroughs in its recent corporate...

Conflict Between Trump and FED Negatively Affects US Markets - Trump's Proposed Capping Pressures Credit Card Companies and Banks - DAX at Record Levels - Submarine Project with India Drives TKMS - XPeng with Product Offensive and Profitable International Business - Beam Therapeutics Benefits from Accelerated Approval Pathway for Liver Drug - Google's Gemini Integrates Walmart

Political shock weighs on Wall Street The US financial markets start the new trading week weakly...

Analysts' Top 5 Price Targets of March 28, 2025

SAF Holland [DE000SAFH001]: Warburg Research reaffirms Buy rating and raises the price target from 25...

  • ‹
  • 1
  • ›